Gaps in accountable measure sets exist among some of the most prevalent and costly conditions, according to a new report from the National Pharmaceutical Council and Discern Health.
Gaps in accountable measure sets exist among some of the most prevalent and costly conditions, according to a new report from the National Pharmaceutical Council and Discern Health.
These gaps in measurement lead to missed opportunities to improve patient care and health systems. Although current accountable care measure sets prioritize population health conditions such as diabetes and heart disease, prevalent and costly conditions are typically not represented.
Although care delivery innovations are being created to address gaps in quality of care, traditional payment systems provide little financial support. In accountable care models, measures are one way to help align financial incentives.
“Better measures can give clinicians more flexibility in reforming care through new personalized services, care teams, and other care innovations, and they can provide better evidence that we are making real progress for all patients in closing gaps in quality and improving outcomes,” Mark McClellan, MD, PhD, director of the Health Care Innovation and Value Initiative at the Brookings Institution and co-chair of the expert advisory group for the project, said in a statement.
The “Accountable Care Measures for High-Cost Specialty Care and Innovative Treatment: You Get What You Pay For” paper examined gaps in measure sets for 20 conditions, including breast cancer, diabetes, HIV, and heart disease, through an analysis of each condition and a roundtable discussion with national thought leaders.
“Gaps in accountable care measure sets cannot be completely addressed with more of the same measure types and measurement strategies currently in use,” said Tom Valuck, MD, JD, MHSA, a partner at Discern Health and co-author of the research. “Measure sets need breadth, depth, and new approaches to promote appropriate care across the relevant population.”
The report outlines a framework to prioritize measure gaps for the most prevalent and costly conditions, use alternative measurement approaches, and address barriers to measurement by enhancing data sources, among other steps.
The authors also highlighted new approaches to measurement:
Outcome measures
Allow for flexibility and innovation in improving care and can replace multiple process measures.
Cross-cutting measures
Assess care across conditions, settings, and time.
Patient-reported measures
Emphasize the outcomes that matter the most to patients, such as functional status and quality of life.
Layered and modular approaches
Optimize measurement efforts by focusing on specific purposes, such as external accountability or internal improvement for the layered approach.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More